Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective
Anders Madsen, Ya-Nan Dai, Meagan McMahon, et al.
Immunity (2020) Vol. 53, Iss. 4, pp. 852-863.e7
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

A pan-influenza antibody inhibiting neuraminidase via receptor mimicry
Corey Momont, Ha V. Dang, Fabrizia Zatta, et al.
Nature (2023) Vol. 618, Iss. 7965, pp. 590-597
Open Access | Times Cited: 53
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
Norbert Pardi, Juan Manuel Carreño, George O’Dell, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
Sarah Creytens, Mirte N. Pascha, Marlies Ballegeer, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
Daniel Ellis, Julia Lederhofer, Oliver J. Acton, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Human Antibodies for Viral Infections
James E. Crowe
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 349-386
Closed Access | Times Cited: 40
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo
Lena Hansen, Meagan McMahon, Hannah L. Turner, et al.
Immunity (2023) Vol. 56, Iss. 8, pp. 1927-1938.e8
Open Access | Times Cited: 27
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase
Ruipeng Lei, Wooseob Kim, Huibin Lv, et al.
Immunity (2023) Vol. 56, Iss. 11, pp. 2621-2634.e6
Closed Access | Times Cited: 25
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
Julia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 574-586.e7
Open Access | Times Cited: 15
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines
Caryn Myn Li Lim, Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 14
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches
Anna Bonomini, Beatrice Mercorelli, Arianna Loregian
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 2
A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
Atsuhiro Yasuhara, Seiya Yamayoshi, Maki Kiso, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model
Shirin Strohmeier, Fatima Amanat, Xueyong Zhu, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 41
Influenza B virus neuraminidase: a potential target for next-generation vaccines?
Thi Hoai Thu, Adam K. Wheatley, Stephen J. Kent, et al.
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 39-48
Open Access | Times Cited: 16
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines
Nicholas C. Wu, Ali H. Ellebedy
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 11-19
Closed Access | Times Cited: 16
Broadly neutralizing antibodies to combat influenza virus infection
Xiaoyu Sun, Hanwen Ma, Xuanjia Wang, et al.
Antiviral Research (2023) Vol. 221, pp. 105785-105785
Closed Access | Times Cited: 16
Influenza vaccine: progress in a vaccine that elicits a broad immune response
Irina Isakova–Sivak, Ekaterina Stepanova, Daria Mezhenskaya, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 9, pp. 1097-1112
Closed Access | Times Cited: 32
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status
Yonggang Zhou, Jinhe Zhang, Dongyao Wang, et al.
Journal of Autoimmunity (2021) Vol. 118, pp. 102596-102596
Open Access | Times Cited: 31
The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
Madhusudan Rajendran, Florian Krammer, Meagan McMahon
Vaccines (2021) Vol. 9, Iss. 8, pp. 846-846
Open Access | Times Cited: 28
Targeting Antigens for Universal Influenza Vaccine Development
Quyen Thi Nguyen, Young Ki Choi
Viruses (2021) Vol. 13, Iss. 6, pp. 973-973
Open Access | Times Cited: 26
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Shirin Strohmeier, Fatima Amanat, John D. Campbell, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 17
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses
Willemijn F. Rijnink, Daniel Stadlbauer, Eduard Puente‐Massaguer, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 10
Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases
Joel Finney, Masayuki Kuraoka, Shengli Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A new strategy to HER2-specific antibody discovery through artificial intelligence-powered phage display screening based on the Trastuzumab framework
Mancang Zhang, Qiangzhen Yang, Jiangrong Lou, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167772-167772
Closed Access
Next-generation seasonal influenza virus vaccines need a neuraminidase component
Florian Krammer
Vaccine (2025) Vol. 54, pp. 126994-126994
Closed Access
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages
Caroline Page, Justin D. Shepard, Sean D. Ray, et al.
Science Advances (2025) Vol. 11, Iss. 13
Open Access
Page 1 - Next Page

Scroll to top